The economic burden of low back pain: a review of studies published between 1996 and 2001 A Maetzel, L Li Best practice & research Clinical rheumatology 16 (1), 23-30, 2002 | 594 | 2002 |
Disability resulting from occupational low back pain: Part II: What do we know about secondary prevention? A review of the scientific evidence on prevention after disability begins JW Frank, AS Brooker, SE DeMaio, MS Kerr, A Maetzel, HS Shannon, ... Spine 21 (24), 2918-2929, 1996 | 571 | 1996 |
Disability resulting from occupational low back pain: Part I: What do we know about primary prevention? A review of the scientific evidence on prevention before disability begins JW Frank, MS Kerr, AS Brooker, SE DeMaio, A Maetzel, HS Shannon, ... Spine 21 (24), 2908-2917, 1996 | 554 | 1996 |
The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: a comparative study A Maetzel, LC Li, J Pencharz, G Tomlinson, C Bombardier Annals of the rheumatic diseases 63 (4), 395-401, 2004 | 364 | 2004 |
Osteoarthritis of the hip and knee and mechanical occupational exposure--a systematic overview of the evidence. A Maetzel, M Mäkelä, G Hawker, C Bombardier The Journal of rheumatology 24 (8), 1599-1607, 1997 | 284 | 1997 |
Meta‐analysis of treatment termination rates among rheumatoid arthritis patients receiving disease‐modifying anti‐rheumatic drugs A Maetzel, A Wong, V Strand, P Tugwell, G Wells, C Bombardier Rheumatology 39 (9), 975-981, 2000 | 257 | 2000 |
Clinical improvement as reflected in measures of function and health‐related quality of life following treatment with leflunomide compared with methotrexate in patients with … P Tugwell, G Wells, V Strand, A Maetzel, C Bombardier, B Crawford, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2000 | 249 | 2000 |
Function and health‐related quality of life: results from a randomized controlled trial of leflunomide versus methotrexate or placebo in patients with active rheumatoid arthritis V Strand, P Tugwell, C Bombardier, A Maetzel, B Crawford, C Dorrier, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1999 | 233 | 1999 |
Long-term antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital S Rüttimann, B Keck, C Hartmeier, A Maetzel, HC Bucher Clinical Infectious Diseases 38 (3), 348-356, 2004 | 211 | 2004 |
Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of epidemiological studies E Aygören-Pürsün, M Magerl, A Maetzel, M Maurer Orphanet journal of rare diseases 13, 1-9, 2018 | 164 | 2018 |
Ottawa panel evidence-based clinical practice guidelines for aerobic walking programs in the management of osteoarthritis L Loew, L Brosseau, GA Wells, P Tugwell, GP Kenny, R Reid, A Maetzel, ... Archives of physical medicine and rehabilitation 93 (7), 1269-1285, 2012 | 150 | 2012 |
The implementation of a community-based aerobic walking program for mild to moderate knee osteoarthritis (OA): a knowledge translation (KT) randomized controlled trial (RCT … L Brosseau, GA Wells, GP Kenny, R Reid, A Maetzel, P Tugwell, ... BMC public health 12, 1-14, 2012 | 138 | 2012 |
A coordinator program in post-fracture osteoporosis management improves outcomes and saves costs B Sander, V Elliot-Gibson, DE Beaton, ER Bogoch, A Maetzel JBJS 90 (6), 1197-1205, 2008 | 130 | 2008 |
The cost‐effectiveness of misoprostol in preventing serious gastrointestinal events associated with the use of nonsteroidal antiinflammatory drugs A Maetzel, MB Ferraz, C Bombardier Arthritis & Rheumatism: Official Journal of the American College of …, 1998 | 110 | 1998 |
The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritis A Maetzel, M Krahn, G Naglie Arthritis Care & Research 49 (3), 283-292, 2003 | 105 | 2003 |
Economic appraisal of Ontario's Universal Influenza Immunization Program: a cost-utility analysis B Sander, JC Kwong, CT Bauch, A Maetzel, A McGeer, JM Raboud, ... PLoS Medicine 7 (4), e1000256, 2010 | 99 | 2010 |
Direct costs of osteoporosis and hip fracture: an analysis for the Mexican healthcare system P Clark, F Carlos, C Barrera, J Guzman, A Maetzel, P Lavielle, E Ramirez, ... Osteoporosis international 19, 269-276, 2008 | 95 | 2008 |
Pharmacoeconomic evaluation of new treatments: efficacy versus effectiveness studies? C Bombardier, A Maetzel Annals of the Rheumatic Diseases 58 (suppl 1), I82-I85, 1999 | 94 | 1999 |
Use of mainstream nonpharmacologic treatment by patients with arthritis LC Li, A Maetzel, JN Pencharz, L Maguire, C Bombardier, ... Arthritis Care & Research 51 (2), 203-209, 2004 | 91 | 2004 |
Community Hypertension and Arthritis Project Study Team. The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: a comparative study A Maetzel, LC Li, J Pencharz, G Tomlinson, C Bombardier Ann Rheum Dis 63 (4), 395-401, 2004 | 91 | 2004 |